Sun Pharma Asks Judge to Freeze Nivagen Suit Pending Transfer

Aug. 18, 2025, 5:58 PM UTC

Sun Pharmaceuticals Industries Inc. urged a Texas federal judge to pause Nivagen Inc.'s lawsuit against it over a neonatal seizure drug until the case’s transfer to New Jersey is finalized.

Nivagen is pressuring Sun to meet deadlines set in an Aug. 4 order, which was filed four days before the court granted transfer to the New Jersey federal court, Sun said in a motion to stay and motion for protective order filed Aug 15 in the US District Court for the Eastern District of Texas. Sun said a stay would allow the New Jersey court to decide on a scheduling ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.